MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Physical therapy practice variability and outcomes for people with Parkinson’s disease: Data from the National Parkinson Foundation quality improvement initiative (NPF-QII)

    M.R. Rafferty, P.N. Schmidt, S.T. Luo, K. Li, F. Cubillos, C. Marras, T. Davis, E.C. Nelson, T. Simuni (Chicago, IL, USA)

    Objective: To (1) describe current variability in physical therapy (PT) use by people with Parkinson's disease (PD) and to (2) examine the association between PT…
  • 2016 International Congress

    Effectiveness of occupational therapy multi-domain group therapy program for Parkinson’s disease

    R.K.M. Wong, D.S.W. Tsang, C.K.Y. Lau, A.Y.Y. Chan, D.T.M. Chan, X. Zhu, W. Poon, V.C.T. Mok (Hong Kong, Hong Kong)

    Objective: This pilot study investigated the effectiveness of an Occupational Therapy (OT) multi-domain group program on preventing fall, improving non-motor symptoms & reducing carers' stress…
  • 2016 International Congress

    Non-contact boxing in Parkinson’s disease

    Z.R. Yee, S.H.X. Liew (Singapore, Singapore)

    Objective: To narratively review the effectiveness of non-contact boxing and explore its feasibility in individuals with Parkinson's disease (PD). Background: Complementary therapies have shown outcomes…
  • 2016 International Congress

    Quality of life and living with Parkinson’s in Ireland

    I. Cassidy, P. Meskell, M.P. Butler, M. Richardson, C. Kennedy, S. Coote, P. Boers (Limerick, Ireland)

    Objective: (1) Assess the quality of life (QoL) for people with Parkinson's and explore associations between (QoL) and demographics (2) Investigate incidence of depression and…
  • 2016 International Congress

    Longitudinal assessment of caregiver strain in Parkinson’s disease

    C.K. Okoro, P. Schmidt, S.S. Wu, J.G. Goldman (Chicago, IL, USA)

    Objective: To examine changes in caregivers and predictors of increased caregiver strain in Parkinson's disease (PD). Background: Caregiver strain can increase with advanced PD. In…
  • 2016 International Congress

    Objective movement recording in PD patient before and after STN-DBS

    D. Flisar, B. Pikš, B. Meglic, Z. Pirtošek, G. Kramberger (Ljubljana, Slovenia)

    Objective: Case study: objective recording of motor fluctuations and dyskinesia in PD patient before and after STN-DBS by using continuous accelerometry system and automated computer…
  • 2016 International Congress

    Quantifying turning behavior in Parkinson’s disease patients using mobile technology

    M. Miller Koop, S.J. Ozinga, J.L. Alberts (Cleveland, OH, USA)

    Objective: To use inertial measurement unit (IMU) data from a mobile device, iPad or iPhone, to quantify PD patients' gait and turning behavior, on and…
  • 2016 International Congress

    Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: Slowly progressive recessive ataxia

    M. Renaud, C. Guissart, S. Ferdinandusse, D. Cheillan, O. Lagha-Boukbiza, M. Mallaret, J. Muller, C. Tranchant, M. Anheim, M. Koenig (Strasbourg cedex, France)

    Objective: Our objective was to report 3 patients with ataxia and unusually prolonged survival caused by missense mutations in the Zinc finger region of PEX10.…
  • 2016 International Congress

    A novel phenotype associated with GRN mutations: Spastic ataxia

    I. Faber, J.R.M. Prota, A.R.M. Martinez, B.S. Carvalho, Í.T. Lopes-Cendes, M.C. França Jr (Campinas, Brazil)

    Objective: We report a patient with Spastic Ataxia caused by new homozygous mutations in the GRN gene. Background: The gene GRN located on chromosome 17…
  • 2016 International Congress

    Parkinson’s disease characteristics in patients with Gaucher’s disease

    A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)

    Objective: To assess the phenotype of Parkinson's disease (PD) patients in homozygote or compound heterozygote carriers of mutations in the β-glucocerebrosidase gene (GBA). Background: Gaucher's…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24752 (not found)
  • An atypical and interesting feature of Parkinson´s disease
  • Fasciculations from a cholinesterase inhibitor
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley